Guinea
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 11.74 (9.47 - 13.58) | 2019 | Modelled | IHME |
| 12.13 (9.77 - 13.96) | 2018 | Modelled | IHME |
| 12.52 (9.95 - 14.56) | 2017 | Modelled | IHME |
| 12.9 (10.27 - 14.90) | 2016 | Modelled | IHME |
| 13.26 (10.50 - 15.49) | 2015 | Modelled | IHME |
| 13.55 (10.80 - 15.69) | 2014 | Modelled | IHME |
| 13.81 (11.13 - 15.89) | 2013 | Modelled | IHME |
| 14.06 (11.50 - 16.16) | 2012 | Modelled | IHME |
| 14.29 (11.73 - 16.51) | 2011 | Modelled | IHME |
| 14.53 (11.86 - 16.98) | 2010 | Modelled | IHME |
| 14.79 (11.96 - 17.23) | 2009 | Modelled | IHME |
| 15.09 (11.98 - 17.64) | 2008 | Modelled | IHME |
| 15.38 (12.05 - 18.08) | 2007 | Modelled | IHME |
| 15.6 (12.03 - 18.50) | 2006 | Modelled | IHME |
| 15.71 (12.04 - 18.70) | 2005 | Modelled | IHME |
| 15.74 (12.18 - 18.60) | 2004 | Modelled | IHME |
| 15.77 (12.29 - 18.41) | 2003 | Modelled | IHME |
| 15.79 (12.38 - 18.34) | 2002 | Modelled | IHME |
| 15.82 (12.52 - 18.40) | 2001 | Modelled | IHME |
| 15.86 (12.55 - 18.52) | 2000 | Modelled | IHME |
| 16.02 (12.69 - 18.57) | 1999 | Modelled | IHME |
| 16.36 (12.84 - 19.09) | 1998 | Modelled | IHME |
| 16.75 (12.96 - 19.75) | 1997 | Modelled | IHME |
| 17.07 (13.03 - 20.30) | 1996 | Modelled | IHME |
| 17.22 (13.07 - 20.54) | 1995 | Modelled | IHME |
| 17.23 (13.20 - 20.37) | 1994 | Modelled | IHME |
| 17.23 (13.26 - 20.28) | 1993 | Modelled | IHME |
| 17.2 (13.37 - 20.14) | 1992 | Modelled | IHME |
| 17.15 (13.39 - 20.01) | 1991 | Modelled | IHME |
| 17.04 (13.35 - 19.77) | 1990 | Modelled | IHME |
| 13 (6.61 - 21.79) | 2015 | Modelled | WHO |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 6.36 (4.26 - 8.06) | 2019 | Modelled | IHME |
| 7.11 (4.61 - 8.82) | 2018 | Modelled | IHME |
| 7.42 (4.75 - 9.38) | 2017 | Modelled | IHME |
| 7.3 (4.65 - 9.23) | 2016 | Modelled | IHME |
| 7.08 (4.50 - 9.15) | 2015 | Modelled | IHME |
| 6.83 (4.34 - 8.85) | 2014 | Modelled | IHME |
| 6.51 (4.15 - 8.41) | 2013 | Modelled | IHME |
| 6.19 (3.99 - 8.03) | 2012 | Modelled | IHME |
| 5.95 (3.83 - 7.81) | 2011 | Modelled | IHME |
| 5.85 (3.76 - 7.88) | 2010 | Modelled | IHME |
| 6.55 (4.21 - 8.65) | 2009 | Modelled | IHME |
| 8.23 (5.28 - 10.70) | 2008 | Modelled | IHME |
| 10.25 (6.53 - 13.25) | 2007 | Modelled | IHME |
| 11.97 (7.59 - 15.39) | 2006 | Modelled | IHME |
| 12.76 (8.17 - 16.50) | 2005 | Modelled | IHME |
| 12.84 (8.43 - 16.22) | 2004 | Modelled | IHME |
| 12.89 (8.63 - 16.27) | 2003 | Modelled | IHME |
| 12.93 (8.73 - 16.20) | 2002 | Modelled | IHME |
| 12.97 (8.89 - 16.54) | 2001 | Modelled | IHME |
| 13.02 (8.95 - 16.60) | 2000 | Modelled | IHME |
| 13.22 (9.10 - 16.70) | 1999 | Modelled | IHME |
| 13.57 (9.09 - 17.22) | 1998 | Modelled | IHME |
| 13.97 (9.12 - 18.09) | 1997 | Modelled | IHME |
| 14.3 (9.21 - 18.79) | 1996 | Modelled | IHME |
| 14.44 (9.23 - 19.16) | 1995 | Modelled | IHME |
| 14.44 (9.23 - 19.13) | 1994 | Modelled | IHME |
| 14.42 (9.26 - 19.06) | 1993 | Modelled | IHME |
| 14.38 (9.27 - 18.94) | 1992 | Modelled | IHME |
| 14.29 (9.20 - 18.51) | 1991 | Modelled | IHME |
| 14.16 (9.03 - 18.11) | 1990 | Modelled | IHME |
| 7.47 (3.70 - 13.98) | 2015 | Modelled | WHO |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 17.9 (13.20 - 23.90) | 2019 | Modelled | IHME |
| 18.6 (13.80 - 24.60) | 2018 | Modelled | IHME |
| 19.1 (14.20 - 25.40) | 2017 | Modelled | IHME |
| 20.1 (15.20 - 26.60) | 2016 | Modelled | IHME |
| 21.1 (16 - 27.60) | 2015 | Modelled | IHME |
| 21.5 (16.50 - 28) | 2014 | Modelled | IHME |
| 21.8 (16.70 - 28.30) | 2013 | Modelled | IHME |
| 22.1 (16.90 - 28.50) | 2012 | Modelled | IHME |
| 22.5 (17.40 - 28.90) | 2011 | Modelled | IHME |
| 23 (17.80 - 29.30) | 2010 | Modelled | IHME |
| 23.5 (18.10 - 29.80) | 2009 | Modelled | IHME |
| 24.5 (18.80 - 30.80) | 2008 | Modelled | IHME |
| 25.7 (19.40 - 32.90) | 2007 | Modelled | IHME |
| 26.7 (19.90 - 35.70) | 2006 | Modelled | IHME |
| 27.4 (20.50 - 36.90) | 2005 | Modelled | IHME |
| 27.3 (20.40 - 36.30) | 2004 | Modelled | IHME |
| 26.9 (20.50 - 34.90) | 2003 | Modelled | IHME |
| 26.6 (20.50 - 34) | 2002 | Modelled | IHME |
| 26.3 (20.60 - 33.30) | 2001 | Modelled | IHME |
| 25.8 (20.30 - 32.50) | 2000 | Modelled | IHME |
| 25.6 (20.20 - 31.70) | 1999 | Modelled | IHME |
| 25.3 (19.90 - 31.40) | 1998 | Modelled | IHME |
| 25.2 (19.80 - 31.50) | 1997 | Modelled | IHME |
| 25.4 (19.90 - 31.60) | 1996 | Modelled | IHME |
| 25.2 (19.70 - 31.60) | 1995 | Modelled | IHME |
| 25.1 (19.60 - 31.30) | 1994 | Modelled | IHME |
| 25.1 (19.60 - 31.10) | 1993 | Modelled | IHME |
| 25.1 (19.60 - 31.10) | 1992 | Modelled | IHME |
| 25 (19.60 - 30.90) | 1991 | Modelled | IHME |
| 25.2 (19.90 - 31.10) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,267 (1,667 - 3,018) | 2019 | Modelled | IHME |
| 2,285 (1,694 - 3,023) | 2018 | Modelled | IHME |
| 2,288 (1,703 - 3,048) | 2017 | Modelled | IHME |
| 2,347 (1,777 - 3,103) | 2016 | Modelled | IHME |
| 2,402 (1,818 - 3,137) | 2015 | Modelled | IHME |
| 2,384 (1,826 - 3,099) | 2014 | Modelled | IHME |
| 2,349 (1,804 - 3,053) | 2013 | Modelled | IHME |
| 2,322 (1,776 - 2,992) | 2012 | Modelled | IHME |
| 2,304 (1,784 - 2,955) | 2011 | Modelled | IHME |
| 2,294 (1,780 - 2,920) | 2010 | Modelled | IHME |
| 2,280 (1,761 - 2,890) | 2009 | Modelled | IHME |
| 2,320 (1,776 - 2,915) | 2008 | Modelled | IHME |
| 2,370 (1,785 - 3,031) | 2007 | Modelled | IHME |
| 2,410 (1,796 - 3,218) | 2006 | Modelled | IHME |
| 2,411 (1,804 - 3,256) | 2005 | Modelled | IHME |
| 2,354 (1,763 - 3,132) | 2004 | Modelled | IHME |
| 2,275 (1,739 - 2,953) | 2003 | Modelled | IHME |
| 2,209 (1,701 - 2,822) | 2002 | Modelled | IHME |
| 2,136 (1,667 - 2,703) | 2001 | Modelled | IHME |
| 2,062 (1,622 - 2,592) | 2000 | Modelled | IHME |
| 2,033 (1,600 - 2,514) | 1999 | Modelled | IHME |
| 1,993 (1,564 - 2,473) | 1998 | Modelled | IHME |
| 1,942 (1,524 - 2,422) | 1997 | Modelled | IHME |
| 1,887 (1,482 - 2,350) | 1996 | Modelled | IHME |
| 1,834 (1,436 - 2,297) | 1995 | Modelled | IHME |
| 1,782 (1,396 - 2,220) | 1994 | Modelled | IHME |
| 1,720 (1,346 - 2,130) | 1993 | Modelled | IHME |
| 1,667 (1,302 - 2,061) | 1992 | Modelled | IHME |
| 1,611 (1,261 - 1,991) | 1991 | Modelled | IHME |
| 1,562 (1,229 - 1,924) | 1990 | Modelled | IHME |
| 2,305 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 53 (45 - 62) | 2019 | Modelled | IHME |
| 53 (45 - 62) | 2018 | Modelled | IHME |
| 53 (45 - 62) | 2017 | Modelled | IHME |
| 54 (46 - 62) | 2016 | Modelled | IHME |
| 54 (46 - 63) | 2015 | Modelled | IHME |
| 54 (46 - 63) | 2014 | Modelled | IHME |
| 54 (46 - 62) | 2013 | Modelled | IHME |
| 54 (46 - 63) | 2012 | Modelled | IHME |
| 54 (45 - 62) | 2011 | Modelled | IHME |
| 54 (45 - 62) | 2010 | Modelled | IHME |
| 53 (45 - 62) | 2009 | Modelled | IHME |
| 53 (45 - 62) | 2008 | Modelled | IHME |
| 54 (45 - 62) | 2007 | Modelled | IHME |
| 53 (45 - 62) | 2006 | Modelled | IHME |
| 53 (45 - 62) | 2005 | Modelled | IHME |
| 53 (45 - 62) | 2004 | Modelled | IHME |
| 53 (45 - 62) | 2003 | Modelled | IHME |
| 53 (44 - 62) | 2002 | Modelled | IHME |
| 53 (44 - 62) | 2001 | Modelled | IHME |
| 53 (44 - 62) | 2000 | Modelled | IHME |
| 53 (44 - 62) | 1999 | Modelled | IHME |
| 53 (44 - 62) | 1998 | Modelled | IHME |
| 53 (44 - 62) | 1997 | Modelled | IHME |
| 53 (44 - 62) | 1996 | Modelled | IHME |
| 53 (44 - 62) | 1995 | Modelled | IHME |
| 53 (44 - 62) | 1994 | Modelled | IHME |
| 53 (44 - 62) | 1993 | Modelled | IHME |
| 53 (44 - 62) | 1992 | Modelled | IHME |
| 53 (44 - 62) | 1991 | Modelled | IHME |
| 53 (44 - 62) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 45 | 2018 | Survey/reported | WHO/UNICEF |
| 45 | 2017 | Survey/reported | WHO/UNICEF |
| 45 | 2016 | Survey/reported | WHO/UNICEF |
| 45 | 2015 | Survey/reported | WHO/UNICEF |
| 44 | 2014 | Survey/reported | WHO/UNICEF |
| 50 | 2013 | Survey/reported | WHO/UNICEF |
| 57 | 2012 | Survey/reported | WHO/UNICEF |
| 63 | 2011 | Survey/reported | WHO/UNICEF |
| 64 | 2010 | Survey/reported | WHO/UNICEF |
| 57 | 2009 | Survey/reported | WHO/UNICEF |
| 57 | 2008 | Survey/reported | WHO/UNICEF |
| 57 | 2007 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.93 (2.34 - 3.69) | 2019 | Modelled | IHME |
| 2.94 (2.36 - 3.69) | 2018 | Modelled | IHME |
| 2.95 (2.36 - 3.69) | 2017 | Modelled | IHME |
| 2.97 (2.38 - 3.69) | 2016 | Modelled | IHME |
| 2.98 (2.40 - 3.70) | 2015 | Modelled | IHME |
| 3.01 (2.42 - 3.72) | 2014 | Modelled | IHME |
| 3.03 (2.45 - 3.75) | 2013 | Modelled | IHME |
| 3.06 (2.47 - 3.79) | 2012 | Modelled | IHME |
| 3.08 (2.49 - 3.83) | 2011 | Modelled | IHME |
| 3.11 (2.51 - 3.89) | 2010 | Modelled | IHME |
| 3.14 (2.53 - 3.92) | 2009 | Modelled | IHME |
| 3.16 (2.54 - 3.95) | 2008 | Modelled | IHME |
| 3.19 (2.56 - 3.99) | 2007 | Modelled | IHME |
| 3.22 (2.59 - 4.03) | 2006 | Modelled | IHME |
| 3.24 (2.59 - 4.07) | 2005 | Modelled | IHME |
| 3.27 (2.62 - 4.10) | 2004 | Modelled | IHME |
| 3.29 (2.65 - 4.13) | 2003 | Modelled | IHME |
| 3.32 (2.68 - 4.15) | 2002 | Modelled | IHME |
| 3.34 (2.71 - 4.17) | 2001 | Modelled | IHME |
| 3.36 (2.72 - 4.21) | 2000 | Modelled | IHME |
| 3.38 (2.73 - 4.23) | 1999 | Modelled | IHME |
| 3.39 (2.74 - 4.25) | 1998 | Modelled | IHME |
| 3.4 (2.74 - 4.27) | 1997 | Modelled | IHME |
| 3.42 (2.75 - 4.29) | 1996 | Modelled | IHME |
| 3.43 (2.75 - 4.30) | 1995 | Modelled | IHME |
| 3.45 (2.78 - 4.32) | 1994 | Modelled | IHME |
| 3.47 (2.81 - 4.34) | 1993 | Modelled | IHME |
| 3.49 (2.82 - 4.38) | 1992 | Modelled | IHME |
| 3.51 (2.82 - 4.40) | 1991 | Modelled | IHME |
| 3.53 (2.84 - 4.42) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 3.56 (2.41 - 4.97) | 2019 | Modelled | IHME |
| 3.68 (2.52 - 5.11) | 2018 | Modelled | IHME |
| 3.76 (2.62 - 5.23) | 2017 | Modelled | IHME |
| 3.75 (2.59 - 5.26) | 2016 | Modelled | IHME |
| 3.78 (2.60 - 5.25) | 2015 | Modelled | IHME |
| 3.86 (2.69 - 5.38) | 2014 | Modelled | IHME |
| 3.97 (2.77 - 5.49) | 2013 | Modelled | IHME |
| 4.07 (2.86 - 5.61) | 2012 | Modelled | IHME |
| 4.18 (2.97 - 5.75) | 2011 | Modelled | IHME |
| 4.29 (3.06 - 5.82) | 2010 | Modelled | IHME |
| 4.35 (3.10 - 5.81) | 2009 | Modelled | IHME |
| 4.46 (3.23 - 5.97) | 2008 | Modelled | IHME |
| 4.53 (3.26 - 6.02) | 2007 | Modelled | IHME |
| 4.6 (3.29 - 6.10) | 2006 | Modelled | IHME |
| 4.69 (3.37 - 6.15) | 2005 | Modelled | IHME |
| 4.71 (3.37 - 6.24) | 2004 | Modelled | IHME |
| 4.71 (3.35 - 6.33) | 2003 | Modelled | IHME |
| 4.73 (3.34 - 6.32) | 2002 | Modelled | IHME |
| 4.74 (3.35 - 6.32) | 2001 | Modelled | IHME |
| 4.72 (3.39 - 6.29) | 2000 | Modelled | IHME |
| 4.68 (3.41 - 6.28) | 1999 | Modelled | IHME |
| 4.6 (3.36 - 6.13) | 1998 | Modelled | IHME |
| 4.59 (3.34 - 6.04) | 1997 | Modelled | IHME |
| 4.61 (3.34 - 6.06) | 1996 | Modelled | IHME |
| 4.57 (3.35 - 5.96) | 1995 | Modelled | IHME |
| 4.55 (3.31 - 5.91) | 1994 | Modelled | IHME |
| 4.56 (3.32 - 5.93) | 1993 | Modelled | IHME |
| 4.57 (3.33 - 5.95) | 1992 | Modelled | IHME |
| 4.56 (3.30 - 5.93) | 1991 | Modelled | IHME |
| 4.61 (3.33 - 6.03) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 450 (305 - 628) | 2019 | Modelled | IHME |
| 454 (311 - 629) | 2018 | Modelled | IHME |
| 451 (314 - 627) | 2017 | Modelled | IHME |
| 438 (302 - 614) | 2016 | Modelled | IHME |
| 430 (295 - 597) | 2015 | Modelled | IHME |
| 428 (298 - 596) | 2014 | Modelled | IHME |
| 429 (299 - 592) | 2013 | Modelled | IHME |
| 428 (301 - 590) | 2012 | Modelled | IHME |
| 428 (304 - 589) | 2011 | Modelled | IHME |
| 428 (306 - 581) | 2010 | Modelled | IHME |
| 422 (301 - 564) | 2009 | Modelled | IHME |
| 422 (306 - 565) | 2008 | Modelled | IHME |
| 417 (300 - 555) | 2007 | Modelled | IHME |
| 414 (296 - 550) | 2006 | Modelled | IHME |
| 413 (297 - 542) | 2005 | Modelled | IHME |
| 406 (291 - 538) | 2004 | Modelled | IHME |
| 399 (284 - 536) | 2003 | Modelled | IHME |
| 393 (277 - 525) | 2002 | Modelled | IHME |
| 384 (272 - 512) | 2001 | Modelled | IHME |
| 377 (271 - 502) | 2000 | Modelled | IHME |
| 371 (271 - 498) | 1999 | Modelled | IHME |
| 362 (264 - 483) | 1998 | Modelled | IHME |
| 353 (257 - 465) | 1997 | Modelled | IHME |
| 343 (248 - 451) | 1996 | Modelled | IHME |
| 333 (243 - 434) | 1995 | Modelled | IHME |
| 323 (235 - 420) | 1994 | Modelled | IHME |
| 312 (228 - 406) | 1993 | Modelled | IHME |
| 303 (221 - 395) | 1992 | Modelled | IHME |
| 294 (213 - 382) | 1991 | Modelled | IHME |
| 285 (206 - 373) | 1990 | Modelled | IHME |
| 617 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 15 (11 - 21) | 2019 | Modelled | IHME |
| 15 (11 - 21) | 2018 | Modelled | IHME |
| 15 (11 - 21) | 2017 | Modelled | IHME |
| 15 (11 - 21) | 2016 | Modelled | IHME |
| 15 (11 - 21) | 2015 | Modelled | IHME |
| 15 (11 - 21) | 2014 | Modelled | IHME |
| 16 (11 - 21) | 2013 | Modelled | IHME |
| 16 (11 - 21) | 2012 | Modelled | IHME |
| 16 (11 - 22) | 2011 | Modelled | IHME |
| 16 (11 - 22) | 2010 | Modelled | IHME |
| 16 (11 - 22) | 2009 | Modelled | IHME |
| 16 (11 - 23) | 2008 | Modelled | IHME |
| 16 (11 - 22) | 2007 | Modelled | IHME |
| 17 (11 - 23) | 2006 | Modelled | IHME |
| 17 (11 - 23) | 2005 | Modelled | IHME |
| 17 (11 - 23) | 2004 | Modelled | IHME |
| 17 (11 - 23) | 2003 | Modelled | IHME |
| 17 (11 - 23) | 2002 | Modelled | IHME |
| 17 (11 - 23) | 2001 | Modelled | IHME |
| 17 (11 - 23) | 2000 | Modelled | IHME |
| 17 (11 - 23) | 1999 | Modelled | IHME |
| 17 (11 - 23) | 1998 | Modelled | IHME |
| 17 (11 - 23) | 1997 | Modelled | IHME |
| 17 (11 - 23) | 1996 | Modelled | IHME |
| 17 (11 - 23) | 1995 | Modelled | IHME |
| 17 (11 - 23) | 1994 | Modelled | IHME |
| 17 (11 - 23) | 1993 | Modelled | IHME |
| 17 (11 - 23) | 1992 | Modelled | IHME |
| 17 (11 - 23) | 1991 | Modelled | IHME |
| 17 (11 - 23) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 300 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
HBV (HBsAg+)
11.74
(%)
2019
(9.47 - 13.58(%))
IHME
HCV (RNA/cAg+)
2.93
(%)
2019
(2.34 - 3.69(%))
IHME
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
2,267
2019
(1,667 - 3,018)
IHME
Survey/surveillance
No data available
HBV chart
Modelled
HCV
450
2019
(305 - 628)
IHME
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
6.36
(%)
2019, latest modelled
(4.26 - 8.06(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines